Medical Care
Global Transthyretin Amyloidosis Treatment Market Research Report 2025
- Mar 11, 25
- ID: 76248
- Pages: 87
- Figures: 89
- Views: 13
The global market for Transthyretin Amyloidosis Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The growth is attributed to the extensive research in the development of new therapies and the presence of robust pipeline drugs that are used to treat transthyretin.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Transthyretin Amyloidosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transthyretin Amyloidosis Treatment.
The Transthyretin Amyloidosis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transthyretin Amyloidosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transthyretin Amyloidosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer Inc.
Johnson & Johnson Services, Inc.
Ionis Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
BridgeBio Pharma, Inc.
Bristol-Myers Squibb Company
Acrotech Biopharma
AstraZeneca
Astellas Pharma, Inc.
Prothena
SOM Biotech
Segment by Type
ATTR-PN
ATTR-CM
Segment by Application
Hospital Pharmacies
Specialty Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transthyretin Amyloidosis Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The growth is attributed to the extensive research in the development of new therapies and the presence of robust pipeline drugs that are used to treat transthyretin.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Transthyretin Amyloidosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transthyretin Amyloidosis Treatment.
The Transthyretin Amyloidosis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transthyretin Amyloidosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transthyretin Amyloidosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer Inc.
Johnson & Johnson Services, Inc.
Ionis Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
BridgeBio Pharma, Inc.
Bristol-Myers Squibb Company
Acrotech Biopharma
AstraZeneca
Astellas Pharma, Inc.
Prothena
SOM Biotech
Segment by Type
ATTR-PN
ATTR-CM
Segment by Application
Hospital Pharmacies
Specialty Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transthyretin Amyloidosis Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transthyretin Amyloidosis Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 ATTR-PN
1.2.3 ATTR-CM
1.3 Market by Application
1.3.1 Global Transthyretin Amyloidosis Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Specialty Pharmacies
1.3.4 Retail Pharmacies
1.3.5 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transthyretin Amyloidosis Treatment Market Perspective (2020-2031)
2.2 Global Transthyretin Amyloidosis Treatment Growth Trends by Region
2.2.1 Global Transthyretin Amyloidosis Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Transthyretin Amyloidosis Treatment Historic Market Size by Region (2020-2025)
2.2.3 Transthyretin Amyloidosis Treatment Forecasted Market Size by Region (2026-2031)
2.3 Transthyretin Amyloidosis Treatment Market Dynamics
2.3.1 Transthyretin Amyloidosis Treatment Industry Trends
2.3.2 Transthyretin Amyloidosis Treatment Market Drivers
2.3.3 Transthyretin Amyloidosis Treatment Market Challenges
2.3.4 Transthyretin Amyloidosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transthyretin Amyloidosis Treatment Players by Revenue
3.1.1 Global Top Transthyretin Amyloidosis Treatment Players by Revenue (2020-2025)
3.1.2 Global Transthyretin Amyloidosis Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Transthyretin Amyloidosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Transthyretin Amyloidosis Treatment Revenue
3.4 Global Transthyretin Amyloidosis Treatment Market Concentration Ratio
3.4.1 Global Transthyretin Amyloidosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transthyretin Amyloidosis Treatment Revenue in 2024
3.5 Global Key Players of Transthyretin Amyloidosis Treatment Head office and Area Served
3.6 Global Key Players of Transthyretin Amyloidosis Treatment, Product and Application
3.7 Global Key Players of Transthyretin Amyloidosis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Transthyretin Amyloidosis Treatment Breakdown Data by Type
4.1 Global Transthyretin Amyloidosis Treatment Historic Market Size by Type (2020-2025)
4.2 Global Transthyretin Amyloidosis Treatment Forecasted Market Size by Type (2026-2031)
5 Transthyretin Amyloidosis Treatment Breakdown Data by Application
5.1 Global Transthyretin Amyloidosis Treatment Historic Market Size by Application (2020-2025)
5.2 Global Transthyretin Amyloidosis Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Transthyretin Amyloidosis Treatment Market Size (2020-2031)
6.2 North America Transthyretin Amyloidosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Transthyretin Amyloidosis Treatment Market Size by Country (2020-2025)
6.4 North America Transthyretin Amyloidosis Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transthyretin Amyloidosis Treatment Market Size (2020-2031)
7.2 Europe Transthyretin Amyloidosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Transthyretin Amyloidosis Treatment Market Size by Country (2020-2025)
7.4 Europe Transthyretin Amyloidosis Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transthyretin Amyloidosis Treatment Market Size (2020-2031)
8.2 Asia-Pacific Transthyretin Amyloidosis Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Transthyretin Amyloidosis Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Transthyretin Amyloidosis Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transthyretin Amyloidosis Treatment Market Size (2020-2031)
9.2 Latin America Transthyretin Amyloidosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Transthyretin Amyloidosis Treatment Market Size by Country (2020-2025)
9.4 Latin America Transthyretin Amyloidosis Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transthyretin Amyloidosis Treatment Market Size (2020-2031)
10.2 Middle East & Africa Transthyretin Amyloidosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Transthyretin Amyloidosis Treatment Introduction
11.1.4 Pfizer Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.1.5 Pfizer Inc. Recent Development
11.2 Johnson & Johnson Services, Inc.
11.2.1 Johnson & Johnson Services, Inc. Company Details
11.2.2 Johnson & Johnson Services, Inc. Business Overview
11.2.3 Johnson & Johnson Services, Inc. Transthyretin Amyloidosis Treatment Introduction
11.2.4 Johnson & Johnson Services, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.2.5 Johnson & Johnson Services, Inc. Recent Development
11.3 Ionis Pharmaceuticals, Inc.
11.3.1 Ionis Pharmaceuticals, Inc. Company Details
11.3.2 Ionis Pharmaceuticals, Inc. Business Overview
11.3.3 Ionis Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Introduction
11.3.4 Ionis Pharmaceuticals, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.3.5 Ionis Pharmaceuticals, Inc. Recent Development
11.4 Alnylam Pharmaceuticals, Inc.
11.4.1 Alnylam Pharmaceuticals, Inc. Company Details
11.4.2 Alnylam Pharmaceuticals, Inc. Business Overview
11.4.3 Alnylam Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Introduction
11.4.4 Alnylam Pharmaceuticals, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.4.5 Alnylam Pharmaceuticals, Inc. Recent Development
11.5 BridgeBio Pharma, Inc.
11.5.1 BridgeBio Pharma, Inc. Company Details
11.5.2 BridgeBio Pharma, Inc. Business Overview
11.5.3 BridgeBio Pharma, Inc. Transthyretin Amyloidosis Treatment Introduction
11.5.4 BridgeBio Pharma, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.5.5 BridgeBio Pharma, Inc. Recent Development
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Details
11.6.2 Bristol-Myers Squibb Company Business Overview
11.6.3 Bristol-Myers Squibb Company Transthyretin Amyloidosis Treatment Introduction
11.6.4 Bristol-Myers Squibb Company Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.6.5 Bristol-Myers Squibb Company Recent Development
11.7 Acrotech Biopharma
11.7.1 Acrotech Biopharma Company Details
11.7.2 Acrotech Biopharma Business Overview
11.7.3 Acrotech Biopharma Transthyretin Amyloidosis Treatment Introduction
11.7.4 Acrotech Biopharma Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.7.5 Acrotech Biopharma Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Transthyretin Amyloidosis Treatment Introduction
11.8.4 AstraZeneca Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.8.5 AstraZeneca Recent Development
11.9 Astellas Pharma, Inc.
11.9.1 Astellas Pharma, Inc. Company Details
11.9.2 Astellas Pharma, Inc. Business Overview
11.9.3 Astellas Pharma, Inc. Transthyretin Amyloidosis Treatment Introduction
11.9.4 Astellas Pharma, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.9.5 Astellas Pharma, Inc. Recent Development
11.10 Prothena
11.10.1 Prothena Company Details
11.10.2 Prothena Business Overview
11.10.3 Prothena Transthyretin Amyloidosis Treatment Introduction
11.10.4 Prothena Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.10.5 Prothena Recent Development
11.11 SOM Biotech
11.11.1 SOM Biotech Company Details
11.11.2 SOM Biotech Business Overview
11.11.3 SOM Biotech Transthyretin Amyloidosis Treatment Introduction
11.11.4 SOM Biotech Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.11.5 SOM Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transthyretin Amyloidosis Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 ATTR-PN
1.2.3 ATTR-CM
1.3 Market by Application
1.3.1 Global Transthyretin Amyloidosis Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Specialty Pharmacies
1.3.4 Retail Pharmacies
1.3.5 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transthyretin Amyloidosis Treatment Market Perspective (2020-2031)
2.2 Global Transthyretin Amyloidosis Treatment Growth Trends by Region
2.2.1 Global Transthyretin Amyloidosis Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Transthyretin Amyloidosis Treatment Historic Market Size by Region (2020-2025)
2.2.3 Transthyretin Amyloidosis Treatment Forecasted Market Size by Region (2026-2031)
2.3 Transthyretin Amyloidosis Treatment Market Dynamics
2.3.1 Transthyretin Amyloidosis Treatment Industry Trends
2.3.2 Transthyretin Amyloidosis Treatment Market Drivers
2.3.3 Transthyretin Amyloidosis Treatment Market Challenges
2.3.4 Transthyretin Amyloidosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transthyretin Amyloidosis Treatment Players by Revenue
3.1.1 Global Top Transthyretin Amyloidosis Treatment Players by Revenue (2020-2025)
3.1.2 Global Transthyretin Amyloidosis Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Transthyretin Amyloidosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Transthyretin Amyloidosis Treatment Revenue
3.4 Global Transthyretin Amyloidosis Treatment Market Concentration Ratio
3.4.1 Global Transthyretin Amyloidosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transthyretin Amyloidosis Treatment Revenue in 2024
3.5 Global Key Players of Transthyretin Amyloidosis Treatment Head office and Area Served
3.6 Global Key Players of Transthyretin Amyloidosis Treatment, Product and Application
3.7 Global Key Players of Transthyretin Amyloidosis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Transthyretin Amyloidosis Treatment Breakdown Data by Type
4.1 Global Transthyretin Amyloidosis Treatment Historic Market Size by Type (2020-2025)
4.2 Global Transthyretin Amyloidosis Treatment Forecasted Market Size by Type (2026-2031)
5 Transthyretin Amyloidosis Treatment Breakdown Data by Application
5.1 Global Transthyretin Amyloidosis Treatment Historic Market Size by Application (2020-2025)
5.2 Global Transthyretin Amyloidosis Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Transthyretin Amyloidosis Treatment Market Size (2020-2031)
6.2 North America Transthyretin Amyloidosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Transthyretin Amyloidosis Treatment Market Size by Country (2020-2025)
6.4 North America Transthyretin Amyloidosis Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transthyretin Amyloidosis Treatment Market Size (2020-2031)
7.2 Europe Transthyretin Amyloidosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Transthyretin Amyloidosis Treatment Market Size by Country (2020-2025)
7.4 Europe Transthyretin Amyloidosis Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transthyretin Amyloidosis Treatment Market Size (2020-2031)
8.2 Asia-Pacific Transthyretin Amyloidosis Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Transthyretin Amyloidosis Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Transthyretin Amyloidosis Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transthyretin Amyloidosis Treatment Market Size (2020-2031)
9.2 Latin America Transthyretin Amyloidosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Transthyretin Amyloidosis Treatment Market Size by Country (2020-2025)
9.4 Latin America Transthyretin Amyloidosis Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transthyretin Amyloidosis Treatment Market Size (2020-2031)
10.2 Middle East & Africa Transthyretin Amyloidosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Transthyretin Amyloidosis Treatment Introduction
11.1.4 Pfizer Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.1.5 Pfizer Inc. Recent Development
11.2 Johnson & Johnson Services, Inc.
11.2.1 Johnson & Johnson Services, Inc. Company Details
11.2.2 Johnson & Johnson Services, Inc. Business Overview
11.2.3 Johnson & Johnson Services, Inc. Transthyretin Amyloidosis Treatment Introduction
11.2.4 Johnson & Johnson Services, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.2.5 Johnson & Johnson Services, Inc. Recent Development
11.3 Ionis Pharmaceuticals, Inc.
11.3.1 Ionis Pharmaceuticals, Inc. Company Details
11.3.2 Ionis Pharmaceuticals, Inc. Business Overview
11.3.3 Ionis Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Introduction
11.3.4 Ionis Pharmaceuticals, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.3.5 Ionis Pharmaceuticals, Inc. Recent Development
11.4 Alnylam Pharmaceuticals, Inc.
11.4.1 Alnylam Pharmaceuticals, Inc. Company Details
11.4.2 Alnylam Pharmaceuticals, Inc. Business Overview
11.4.3 Alnylam Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Introduction
11.4.4 Alnylam Pharmaceuticals, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.4.5 Alnylam Pharmaceuticals, Inc. Recent Development
11.5 BridgeBio Pharma, Inc.
11.5.1 BridgeBio Pharma, Inc. Company Details
11.5.2 BridgeBio Pharma, Inc. Business Overview
11.5.3 BridgeBio Pharma, Inc. Transthyretin Amyloidosis Treatment Introduction
11.5.4 BridgeBio Pharma, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.5.5 BridgeBio Pharma, Inc. Recent Development
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Details
11.6.2 Bristol-Myers Squibb Company Business Overview
11.6.3 Bristol-Myers Squibb Company Transthyretin Amyloidosis Treatment Introduction
11.6.4 Bristol-Myers Squibb Company Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.6.5 Bristol-Myers Squibb Company Recent Development
11.7 Acrotech Biopharma
11.7.1 Acrotech Biopharma Company Details
11.7.2 Acrotech Biopharma Business Overview
11.7.3 Acrotech Biopharma Transthyretin Amyloidosis Treatment Introduction
11.7.4 Acrotech Biopharma Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.7.5 Acrotech Biopharma Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Transthyretin Amyloidosis Treatment Introduction
11.8.4 AstraZeneca Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.8.5 AstraZeneca Recent Development
11.9 Astellas Pharma, Inc.
11.9.1 Astellas Pharma, Inc. Company Details
11.9.2 Astellas Pharma, Inc. Business Overview
11.9.3 Astellas Pharma, Inc. Transthyretin Amyloidosis Treatment Introduction
11.9.4 Astellas Pharma, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.9.5 Astellas Pharma, Inc. Recent Development
11.10 Prothena
11.10.1 Prothena Company Details
11.10.2 Prothena Business Overview
11.10.3 Prothena Transthyretin Amyloidosis Treatment Introduction
11.10.4 Prothena Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.10.5 Prothena Recent Development
11.11 SOM Biotech
11.11.1 SOM Biotech Company Details
11.11.2 SOM Biotech Business Overview
11.11.3 SOM Biotech Transthyretin Amyloidosis Treatment Introduction
11.11.4 SOM Biotech Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025)
11.11.5 SOM Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Transthyretin Amyloidosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of ATTR-PN
Table 3. Key Players of ATTR-CM
Table 4. Global Transthyretin Amyloidosis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Transthyretin Amyloidosis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Transthyretin Amyloidosis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Transthyretin Amyloidosis Treatment Market Share by Region (2020-2025)
Table 8. Global Transthyretin Amyloidosis Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Transthyretin Amyloidosis Treatment Market Share by Region (2026-2031)
Table 10. Transthyretin Amyloidosis Treatment Market Trends
Table 11. Transthyretin Amyloidosis Treatment Market Drivers
Table 12. Transthyretin Amyloidosis Treatment Market Challenges
Table 13. Transthyretin Amyloidosis Treatment Market Restraints
Table 14. Global Transthyretin Amyloidosis Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Transthyretin Amyloidosis Treatment Market Share by Players (2020-2025)
Table 16. Global Top Transthyretin Amyloidosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Amyloidosis Treatment as of 2024)
Table 17. Ranking of Global Top Transthyretin Amyloidosis Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Transthyretin Amyloidosis Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Transthyretin Amyloidosis Treatment, Headquarters and Area Served
Table 20. Global Key Players of Transthyretin Amyloidosis Treatment, Product and Application
Table 21. Global Key Players of Transthyretin Amyloidosis Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Transthyretin Amyloidosis Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Transthyretin Amyloidosis Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Transthyretin Amyloidosis Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Transthyretin Amyloidosis Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Transthyretin Amyloidosis Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Transthyretin Amyloidosis Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Transthyretin Amyloidosis Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Transthyretin Amyloidosis Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Transthyretin Amyloidosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Transthyretin Amyloidosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Transthyretin Amyloidosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Transthyretin Amyloidosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Transthyretin Amyloidosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Transthyretin Amyloidosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Transthyretin Amyloidosis Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Transthyretin Amyloidosis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Transthyretin Amyloidosis Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Transthyretin Amyloidosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Transthyretin Amyloidosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Transthyretin Amyloidosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Pfizer Inc. Company Details
Table 47. Pfizer Inc. Business Overview
Table 48. Pfizer Inc. Transthyretin Amyloidosis Treatment Product
Table 49. Pfizer Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 50. Pfizer Inc. Recent Development
Table 51. Johnson & Johnson Services, Inc. Company Details
Table 52. Johnson & Johnson Services, Inc. Business Overview
Table 53. Johnson & Johnson Services, Inc. Transthyretin Amyloidosis Treatment Product
Table 54. Johnson & Johnson Services, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 55. Johnson & Johnson Services, Inc. Recent Development
Table 56. Ionis Pharmaceuticals, Inc. Company Details
Table 57. Ionis Pharmaceuticals, Inc. Business Overview
Table 58. Ionis Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Product
Table 59. Ionis Pharmaceuticals, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 60. Ionis Pharmaceuticals, Inc. Recent Development
Table 61. Alnylam Pharmaceuticals, Inc. Company Details
Table 62. Alnylam Pharmaceuticals, Inc. Business Overview
Table 63. Alnylam Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Product
Table 64. Alnylam Pharmaceuticals, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 65. Alnylam Pharmaceuticals, Inc. Recent Development
Table 66. BridgeBio Pharma, Inc. Company Details
Table 67. BridgeBio Pharma, Inc. Business Overview
Table 68. BridgeBio Pharma, Inc. Transthyretin Amyloidosis Treatment Product
Table 69. BridgeBio Pharma, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 70. BridgeBio Pharma, Inc. Recent Development
Table 71. Bristol-Myers Squibb Company Company Details
Table 72. Bristol-Myers Squibb Company Business Overview
Table 73. Bristol-Myers Squibb Company Transthyretin Amyloidosis Treatment Product
Table 74. Bristol-Myers Squibb Company Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 75. Bristol-Myers Squibb Company Recent Development
Table 76. Acrotech Biopharma Company Details
Table 77. Acrotech Biopharma Business Overview
Table 78. Acrotech Biopharma Transthyretin Amyloidosis Treatment Product
Table 79. Acrotech Biopharma Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 80. Acrotech Biopharma Recent Development
Table 81. AstraZeneca Company Details
Table 82. AstraZeneca Business Overview
Table 83. AstraZeneca Transthyretin Amyloidosis Treatment Product
Table 84. AstraZeneca Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 85. AstraZeneca Recent Development
Table 86. Astellas Pharma, Inc. Company Details
Table 87. Astellas Pharma, Inc. Business Overview
Table 88. Astellas Pharma, Inc. Transthyretin Amyloidosis Treatment Product
Table 89. Astellas Pharma, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 90. Astellas Pharma, Inc. Recent Development
Table 91. Prothena Company Details
Table 92. Prothena Business Overview
Table 93. Prothena Transthyretin Amyloidosis Treatment Product
Table 94. Prothena Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 95. Prothena Recent Development
Table 96. SOM Biotech Company Details
Table 97. SOM Biotech Business Overview
Table 98. SOM Biotech Transthyretin Amyloidosis Treatment Product
Table 99. SOM Biotech Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 100. SOM Biotech Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Transthyretin Amyloidosis Treatment Picture
Figure 2. Global Transthyretin Amyloidosis Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Transthyretin Amyloidosis Treatment Market Share by Type: 2024 VS 2031
Figure 4. ATTR-PN Features
Figure 5. ATTR-CM Features
Figure 6. Global Transthyretin Amyloidosis Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Transthyretin Amyloidosis Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Specialty Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Transthyretin Amyloidosis Treatment Report Years Considered
Figure 13. Global Transthyretin Amyloidosis Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Transthyretin Amyloidosis Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Transthyretin Amyloidosis Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Transthyretin Amyloidosis Treatment Market Share by Players in 2024
Figure 17. Global Top Transthyretin Amyloidosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Amyloidosis Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Transthyretin Amyloidosis Treatment Revenue in 2024
Figure 19. North America Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Transthyretin Amyloidosis Treatment Market Share by Country (2020-2031)
Figure 21. United States Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Transthyretin Amyloidosis Treatment Market Share by Country (2020-2031)
Figure 25. Germany Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Transthyretin Amyloidosis Treatment Market Share by Region (2020-2031)
Figure 33. China Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Transthyretin Amyloidosis Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Transthyretin Amyloidosis Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Pfizer Inc. Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 49. Johnson & Johnson Services, Inc. Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 50. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 51. Alnylam Pharmaceuticals, Inc. Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 52. BridgeBio Pharma, Inc. Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 53. Bristol-Myers Squibb Company Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 54. Acrotech Biopharma Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 55. AstraZeneca Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 56. Astellas Pharma, Inc. Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 57. Prothena Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 58. SOM Biotech Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Transthyretin Amyloidosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of ATTR-PN
Table 3. Key Players of ATTR-CM
Table 4. Global Transthyretin Amyloidosis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Transthyretin Amyloidosis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Transthyretin Amyloidosis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Transthyretin Amyloidosis Treatment Market Share by Region (2020-2025)
Table 8. Global Transthyretin Amyloidosis Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Transthyretin Amyloidosis Treatment Market Share by Region (2026-2031)
Table 10. Transthyretin Amyloidosis Treatment Market Trends
Table 11. Transthyretin Amyloidosis Treatment Market Drivers
Table 12. Transthyretin Amyloidosis Treatment Market Challenges
Table 13. Transthyretin Amyloidosis Treatment Market Restraints
Table 14. Global Transthyretin Amyloidosis Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Transthyretin Amyloidosis Treatment Market Share by Players (2020-2025)
Table 16. Global Top Transthyretin Amyloidosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Amyloidosis Treatment as of 2024)
Table 17. Ranking of Global Top Transthyretin Amyloidosis Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Transthyretin Amyloidosis Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Transthyretin Amyloidosis Treatment, Headquarters and Area Served
Table 20. Global Key Players of Transthyretin Amyloidosis Treatment, Product and Application
Table 21. Global Key Players of Transthyretin Amyloidosis Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Transthyretin Amyloidosis Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Transthyretin Amyloidosis Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Transthyretin Amyloidosis Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Transthyretin Amyloidosis Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Transthyretin Amyloidosis Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Transthyretin Amyloidosis Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Transthyretin Amyloidosis Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Transthyretin Amyloidosis Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Transthyretin Amyloidosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Transthyretin Amyloidosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Transthyretin Amyloidosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Transthyretin Amyloidosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Transthyretin Amyloidosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Transthyretin Amyloidosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Transthyretin Amyloidosis Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Transthyretin Amyloidosis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Transthyretin Amyloidosis Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Transthyretin Amyloidosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Transthyretin Amyloidosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Transthyretin Amyloidosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Pfizer Inc. Company Details
Table 47. Pfizer Inc. Business Overview
Table 48. Pfizer Inc. Transthyretin Amyloidosis Treatment Product
Table 49. Pfizer Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 50. Pfizer Inc. Recent Development
Table 51. Johnson & Johnson Services, Inc. Company Details
Table 52. Johnson & Johnson Services, Inc. Business Overview
Table 53. Johnson & Johnson Services, Inc. Transthyretin Amyloidosis Treatment Product
Table 54. Johnson & Johnson Services, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 55. Johnson & Johnson Services, Inc. Recent Development
Table 56. Ionis Pharmaceuticals, Inc. Company Details
Table 57. Ionis Pharmaceuticals, Inc. Business Overview
Table 58. Ionis Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Product
Table 59. Ionis Pharmaceuticals, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 60. Ionis Pharmaceuticals, Inc. Recent Development
Table 61. Alnylam Pharmaceuticals, Inc. Company Details
Table 62. Alnylam Pharmaceuticals, Inc. Business Overview
Table 63. Alnylam Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Product
Table 64. Alnylam Pharmaceuticals, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 65. Alnylam Pharmaceuticals, Inc. Recent Development
Table 66. BridgeBio Pharma, Inc. Company Details
Table 67. BridgeBio Pharma, Inc. Business Overview
Table 68. BridgeBio Pharma, Inc. Transthyretin Amyloidosis Treatment Product
Table 69. BridgeBio Pharma, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 70. BridgeBio Pharma, Inc. Recent Development
Table 71. Bristol-Myers Squibb Company Company Details
Table 72. Bristol-Myers Squibb Company Business Overview
Table 73. Bristol-Myers Squibb Company Transthyretin Amyloidosis Treatment Product
Table 74. Bristol-Myers Squibb Company Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 75. Bristol-Myers Squibb Company Recent Development
Table 76. Acrotech Biopharma Company Details
Table 77. Acrotech Biopharma Business Overview
Table 78. Acrotech Biopharma Transthyretin Amyloidosis Treatment Product
Table 79. Acrotech Biopharma Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 80. Acrotech Biopharma Recent Development
Table 81. AstraZeneca Company Details
Table 82. AstraZeneca Business Overview
Table 83. AstraZeneca Transthyretin Amyloidosis Treatment Product
Table 84. AstraZeneca Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 85. AstraZeneca Recent Development
Table 86. Astellas Pharma, Inc. Company Details
Table 87. Astellas Pharma, Inc. Business Overview
Table 88. Astellas Pharma, Inc. Transthyretin Amyloidosis Treatment Product
Table 89. Astellas Pharma, Inc. Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 90. Astellas Pharma, Inc. Recent Development
Table 91. Prothena Company Details
Table 92. Prothena Business Overview
Table 93. Prothena Transthyretin Amyloidosis Treatment Product
Table 94. Prothena Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 95. Prothena Recent Development
Table 96. SOM Biotech Company Details
Table 97. SOM Biotech Business Overview
Table 98. SOM Biotech Transthyretin Amyloidosis Treatment Product
Table 99. SOM Biotech Revenue in Transthyretin Amyloidosis Treatment Business (2020-2025) & (US$ Million)
Table 100. SOM Biotech Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Transthyretin Amyloidosis Treatment Picture
Figure 2. Global Transthyretin Amyloidosis Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Transthyretin Amyloidosis Treatment Market Share by Type: 2024 VS 2031
Figure 4. ATTR-PN Features
Figure 5. ATTR-CM Features
Figure 6. Global Transthyretin Amyloidosis Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Transthyretin Amyloidosis Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Specialty Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Transthyretin Amyloidosis Treatment Report Years Considered
Figure 13. Global Transthyretin Amyloidosis Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Transthyretin Amyloidosis Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Transthyretin Amyloidosis Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Transthyretin Amyloidosis Treatment Market Share by Players in 2024
Figure 17. Global Top Transthyretin Amyloidosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Amyloidosis Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Transthyretin Amyloidosis Treatment Revenue in 2024
Figure 19. North America Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Transthyretin Amyloidosis Treatment Market Share by Country (2020-2031)
Figure 21. United States Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Transthyretin Amyloidosis Treatment Market Share by Country (2020-2031)
Figure 25. Germany Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Transthyretin Amyloidosis Treatment Market Share by Region (2020-2031)
Figure 33. China Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Transthyretin Amyloidosis Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Transthyretin Amyloidosis Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Transthyretin Amyloidosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Pfizer Inc. Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 49. Johnson & Johnson Services, Inc. Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 50. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 51. Alnylam Pharmaceuticals, Inc. Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 52. BridgeBio Pharma, Inc. Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 53. Bristol-Myers Squibb Company Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 54. Acrotech Biopharma Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 55. AstraZeneca Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 56. Astellas Pharma, Inc. Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 57. Prothena Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 58. SOM Biotech Revenue Growth Rate in Transthyretin Amyloidosis Treatment Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Cutting Machines for Diamond Market Research Report 2025
Jul 18, 25
Global RF Shielded Enclosures Market Research Report 2025
Jul 18, 25
Global Padel Court Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232